Voxel8 Announces Series B Funding Round to Advance Its Multi-Material Digital Fabrication

Share this Article

Massachusetts-based Voxel8 was co-founded in 2014 by an interdisciplinary team of scientists and engineers from Harvard University, led by Dr. Jennifer Lewis. The company is working to develop digital manufacturing systems that will change up how we design, manufacture, and sell footwear and athletic apparel around the world.

Not long ago, the company introduced its multi-material ActiveLab Digital Fabrication System, which allows for the product development, wear testing, and production runs of high-performance athletic shoe uppers, in addition to other textiles. It’s designer-friendly, enabling automation and customization with zero tooling costs. The system uses ActiveMix extrusion technology to build 3D structures and thick films with variable cross sections directly on to textiles.

The 600 kg printer, with a 600 x 430 mm build platform, allows users to digitally design and fabricate shoe uppers, and is transforming how we develop and manufacture footwear and athletic apparel today. The system offers shorter manufacturing reorder lead times, significantly reduced design cycle times, and much lower costs for freight, labor, tariffs, and tooling. This gives customers the ability to design shoes, and other textile products, that include structural features and complex designs with little extra cost – affording them the opportunity to set up manufacturing facilities that are located closer to major end-user markets, like Europe and North America, and respond much faster to consumer demand.

Voxel8 seems to be doing pretty well for itself, and has just announced a Series B investment funding round, which was led by DSM Venturing – the venture investment arm of Royal DSM.

“Voxel8 is an excellent addition to our portfolio. Its multi-materials digital manufacturing platform is poised to dramatically impact the footwear and the sports apparel markets, strategic to DSM,” stated Pieter Wolters, Managing Director for DSM Venturing.

Additional participants in this round of Series B funding include HP Tech Ventures, as well as ARCH Venture Partners and Braemar Energy Ventures – two of Voxel8’s existing investors.

“Voxel8 is uniquely differentiated as a leader in multi-material digital manufacturing, which we believe will meaningfully expand the realm of possibilities for digitally manufacturing a wide range of products. Within the athletic footwear market alone, over 2.5 billion pairs of athletic shoes are manufactured globally each year,” said Jiong Ma, Braemar Energy Ventures. “Voxel8 is well-poised to capture substantial market share in athletic shoe upper manufacturing and, more broadly, medical and smart textiles.”

The company will use the funding to continue advancing its multi-material digital manufacturing.

“Our digital manufacturing systems are revolutionizing how footwear and athletic apparel is designed, manufactured, and sold to consumers across the globe,” said Travis Busbee, the CEO and co-founder of Voxel8. “We are excited to work with this team of world-class and experienced investors. Their global reach, expertise, and funding will accelerate the rapid adoption of Voxel8’s technology for high-volume production of athletic footwear and apparel.”

What do you think about this news? Discuss this story and other 3D printing topics at 3DPrintBoard.com or share your thoughts in the Facebook comments below. 

[Images: Voxel8]

Share this Article


Recent News

Korea: 3D Printing Pregabalin Tablets for Successful & Controlled Release

Researchers 3D Print Six Different Drugs in Multi-Layered Polypill



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

SLS 3D Printing for 3D Printed Pellets for Multi-Drug Controlled Release

In ‘3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology,’ international researchers explore better ways to deliver medications via SLS 3D printing in oral form. For this study,...

FDM 3D Printing Shows Great Potential in Transformation of Pharmaceutical Production

In the recently published, ‘The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality,’ Brazilian researchers further examine the potential of new technology for...

Finland: 3D Printing Patient-Specific Doses of Warfarin for Children

Finnish researchers reach further into the potential of 3D printed medications, outlining their findings in the recently published ‘Towards Printed Pediatric Medicines in Hospital Pharmacies: Comparison of 2D and 3D...

Researchers Recognize Transformative Power of 3D Printed Pharmaceuticals

Authors Ghadge Snehal, Aloorkar Nagesh, and Sudake Suresh from the Satara College of Pharmacy explore 3D printing of medication, and the possibilities for the future in ‘A Decisive Overview on Three Dimensional...


Shop

View our broad assortment of in house and third party products.


Services & Data

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our 3DPrint.com.

You have Successfully Subscribed!